Posters
« Back
Novel Gpr39 Agonists: Correlation Of Binding Affinity Using Label-Free Back-Scattering Interferometry With Potency In Functional Assays
EP22213
Poster Title: Novel Gpr39 Agonists: Correlation Of Binding Affinity Using Label-Free Back-Scattering Interferometry With Potency In Functional Assays
Submitted on 02 Sep 2014
Author(s): Daniel Brown (1), Niklas Larsson (2), Ola Fjellström (3), Anders Johansson (3), Sara Lundqvist (2), Johan Brengdahl (2), and Richard J. Isaacs (1)
Affiliations: (1) Molecular Sensing, Inc., Nashville, Tennessee, USA, (2) AstraZeneca Discovery Sciences, Mölndal, Sweden, (3) AstraZeneca CVMD iMED, Mölndal, Sweden
This poster was presented at ELRIG Drug Discovery 2014
Poster Views: 2,257
View poster »


Poster Information
Abstract: Back-scattering interferometry (BSI) is an emerging label-free, conformation-sensitive detection technology for quantitative mass- and matrix-independent biophysical characterization of small molecule interaction with complex drug target proteins under native-like conditions (1). Integral membrane proteins such as GPCRs are critical targets for drug discovery but present a host of challenges to the investigation of their biophysical properties. Of paramount interest to drug discovery efforts is the characterization of the interaction of GPCRs with small molecule compounds as a component of library screening, mechanism of action (MOA) determination, drug candidate profiling, and other aspects of intermolecular binding that inform pharmacology and medicinal chemistry. The difficulty associated with obtaining small molecule affinity data for functionally intact GPCRs effectively restricts the range of assay techniques suited to quantifying these interactions in vitro.

Herein, we describe the application of BSI to the characterization of small molecule ligand binding to human GPR39 overexpressed in crude membrane fractions in free solution. GPR39 is a Zn2+-responsive GPCR under investigation as a therapeutic target for type-2 diabetes (2). The ability to measure the affinity of small molecule agonists such as Zn2+is especially novel, given the unfavorable mass ratio and fast off rate that complicates the use of more established binding assays. Results from screening representatives from multiple novel GPR39 agonist series is presented, including how BSI-derived affinity and functional assay-derived potency correlate for compounds of varying scaffolds.
Summary: We describe the application of back-scattering interferometry (BSI) to the characterization of small molecule ligand binding to human GPR39 (a GPCR targeted for type-2 diabetes therapy) overexpressed in crude membrane fractions in free solution, including how BSI-derived affinity and functional assay-derived potency correlate for compounds of varying scaffoldsReferences: 1. Bornhop DJ, Latham JC, Kussrow A, Markov DA, Jones RD, Sorensen HS. Free-solution, label-free molecular interactions studied by back-scattering interferometry. Science. 2007 Sep 21;317(5845):1732-6.

2. Popovics P, Stewart AJ. GPR39: A zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions. Cell Mol Life Sci. 2011 Jan;68(1):85-95.
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Genetic Engineering in Male Sterility for Hybrid Variety Development
Abir Hasan Joy

VITVO: Mimicking In Vivo Complexity By The Innovative 3D Model
Olivia Candini1, Giulia Grisendi1, Elisabetta Manuela Foppiani1, Matteo Brogli1, Beatrice Aramini2, Valentina Masciale3, Carlotta Spano1, Tiziana Petrachi4, Elena Veronesi4, Pierfranco Conte5,6, Giorgio Mari1 & Massimo Dominici1,3

Digiceuticals
Helana Lutfi and Shaban Nuredini

Characterization of patient-derived organoids cultured on a gas-rich, liquid-liquid interface
James T. Shoemaker, Katherine R. Richardson, Jamie Arnst, Adam Marcus, Jelena Vukasinovic

Revolution to Blood Transfusion: The One-Size-Fits-All Artificial Blood
Yi Wen Tay, Geok Fong Ong, Sheh Wen Kuan, Doris Ying Ying Tang, Sweet Mun Wong, Athirah Nurhuda Abdul Razak, Nadia Asyikin Muhammad Rabuan, Nurul Aini Atikah Sidek, Nurain Chow Effandy Chow